Fragment-based discovery of JAK-2 inhibitors

被引：69

作者：

Antonysamy, Stephen ^{[1
]}

Hirst, Gavin ^{[1
]}

Park, Frances ^{[1
]}

Sprengeler, Paul ^{[1
]}

Stappenbeck, Frank ^{[1
]}

Steensma, Ruo ^{[1
]}

Wilson, Mark ^{[1
]}

Wong, Melissa ^{[1
]}

机构：

[1] SGX Pharmaceut Inc, Med Chem, San Diego, CA 92121 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2009年 / 19卷 / 01期

关键词：

Fragment-based design; JAK-2; inhibitors; Structure-based design; Aminoindazole; Kinase inhibitors; MYELOPROLIFERATIVE DISORDERS; JAK/STAT PATHWAY; STATS;

D O I：

10.1016/j.bmcl.2008.08.064

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Fragment-based hit identification coupled with crystallographically enabled structure-based drug design was used to design potent inhibitors of JAK-2. After two iterations from fragment 1, we were able to increase potency by greater than 500-fold to provide sulfonamide 13, a 78-nM JAK-2 inhibitor. (C) 2008 Published by Elsevier Ltd.

引用

页码：279 / 282

页数：4

共 50 条

[11] Discovery of KATII inhibitors via a fragment-based approach
Han, Ying
Stachura, Sylwia
McClure, Andrea
Cavallaro, Cullen
Allard, Christopher
Rajamani, Ramkumar
Yong, Wei
Lewis, Hal
Muckelbauer, Jodi
Loughney, Deborah
Metzler, William
Nirschl, David
Weller, Harold
Gerritz, Sam
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
[12] Fragment-Based Discovery of Inhibitors of Protein Kinase B
Davies, Thomas G.
Woodhead, Steven J.
Collins, Ian
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (18) : 1705 - 1717
[13] Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides
Bamborough, Paul
Diallo, Hawa
Goodacre, Jonathan D.
Gordon, Laurie
Lewis, Antonia
Seal, Jonathan T.
Wilson, David M.
Woodrow, Michael D.
Chung, Chun-wa
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (02) : 587 - 596
[14] Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
Murray, Christopher W.
Berdini, Valerio
Buck, Ildiko M.
Carr, Maria E.
Cleasby, Anne
Coyle, Joseph E.
Curry, Jayne E.
Day, James E. H.
Day, Phillip J.
Hearn, Keisha
Iqbal, Aman
Lee, Lydia Y. W.
Martins, Vanessa
Mortenson, Paul N.
Munck, Joanne M.
Page, Lee W.
Patel, Sahil
Roomans, Susan
Smith, Kirsten
Tamanini, Emiliano
Saxty, Gordon
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07): : 798 - 803
[15] Fragment-Based Discovery of Novel MUS81 Inhibitors
Collie, Gavin W.
Borjesson, Ulf
Chen, Yunhua
Dong, Zhiqiang
Di Fruscia, Paolo
Gohlke, Andrea
Hoyle, Anna
Hunt, Thomas A.
Jesani, Mehul H.
Luo, Haiou
Luptak, Jakub
Milbradt, Alexander G.
Narasimhan, Priyanka
Packer, Martin
Patel, Saleha
Qiao, Jingchuan
Storer, R. Ian
Stubbs, Christopher J.
Tart, Jonathan
Truman, Caroline
Wang, Anderson T.
Wheeler, Matthew G.
Winter-Holt, Jon
ACS MEDICINAL CHEMISTRY LETTERS, 2024, 15 (07): : 1151 - 1158
[16] Fragment-Based Discovery of Novel Potent Sepiapterin Reductase Inhibitors
Alen, Jo
Schade, Markus
Wagener, Markus
Christian, Frank
Nordhoff, Sonja
Merla, Beatrix
Dunkern, Torsten R.
Bahrenberg, Gregor
Ratcliffe, Paul
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6391 - 6397
[17] Fragment-based and structure-guided discovery of perforin inhibitors
Jose, Jiney
Law, Ruby H. P.
Leung, Eleanor W. W.
Wai, Dorothy C. C.
Akhlaghi, Hedieh
Chandrashekaran, Indu R.
Caradoc-Davies, Tom T.
Voskoboinik, Ilia
Feutrill, John
Middlemiss, David
Jeevarajah, Devadharshini
Bashtannyk-Puhalovich, Tanya
Giddens, Anna C.
Lee, Tet Woo
Jamieson, Stephen M. F.
Trapani, Joseph A.
Whisstock, James C.
Spicer, Julie A.
Norton, Raymond S.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 261
[18] Discovery of Plasmepsin Inhibitors by Fragment-Based Docking and Consensus Scoring
Friedman, Ran
Caflisch, Amedeo
CHEMMEDCHEM, 2009, 4 (08) : 1317 - 1326
[19] Fragment-based discovery and optimization of BACE1 inhibitors
Madden, James
Dod, Jenny R.
Godemann, Robert
Kraemer, Joachim
Smith, Myron
Biniszkiewicz, Marion
Hallett, David J.
Barker, John
Dyekjaer, Jane D.
Hesterkamp, Thomas
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (17) : 5329 - 5333
[20] Fragment-based lead discovery
David C. Rees
Miles Congreve,
Christopher W. Murray
Robin Carr
Nature Reviews Drug Discovery, 2004, 3 : 660 - 672

← 1 2 3 4 5 →